KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Accounts Payables (2016 - 2025)

Vertex Pharmaceuticals has reported Accounts Payables over the past 17 years, most recently at $461.7 million for Q4 2025.

  • Quarterly results put Accounts Payables at $461.7 million for Q4 2025, up 11.79% from a year ago — trailing twelve months through Dec 2025 was $461.7 million (up 11.79% YoY), and the annual figure for FY2025 was $461.7 million, up 11.79%.
  • Accounts Payables for Q4 2025 was $461.7 million at Vertex Pharmaceuticals, up from $420.3 million in the prior quarter.
  • Over the last five years, Accounts Payables for VRTX hit a ceiling of $461.7 million in Q4 2025 and a floor of $126.9 million in Q3 2022.
  • Median Accounts Payables over the past 5 years was $339.6 million (2024), compared with a mean of $303.3 million.
  • Biggest five-year swings in Accounts Payables: skyrocketed 196.22% in 2023 and later dropped 9.67% in 2024.
  • Vertex Pharmaceuticals' Accounts Payables stood at $195.0 million in 2021, then surged by 55.85% to $303.9 million in 2022, then increased by 20.07% to $364.9 million in 2023, then rose by 13.18% to $413.0 million in 2024, then rose by 11.79% to $461.7 million in 2025.
  • The last three reported values for Accounts Payables were $461.7 million (Q4 2025), $420.3 million (Q3 2025), and $442.3 million (Q2 2025) per Business Quant data.